SCHEMBL6129773

SCHEMBL6129773

CCN1CCCC1(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4166487 0.77
SCHEMBL28700224 0.76
SCHEMBL29431938 0.76
SCHEMBL14565274 0.74
SCHEMBL19120916 0.72
SCHEMBL19121218 0.72 ROCK2 (0.32)
SCHEMBL9278566 0.72
SCHEMBL19121494 0.72 ROCK2 (0.34)
SCHEMBL8895901 0.72 INMT (0.31)
SCHEMBL8896203 0.72 INMT (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534889-B2 For reduced motility of gastrointestinal tract; irritable bowel syndrome (IBS), chronic constipation, dyspepsia, reflux disease; 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid ((1S,3R,5R)-8-{3-[(2-ethylsulfanylethyl)methanesulfonylamino]-2-hydroxypropyl}-8-aza-bicyclo[3.2.1]oct-3-yl)amide THERAVANCE, INC. (US) 2009-05-19 US disclosed
US-20080255187-A1 5-HT4 RECEPTOR AGONIST COMPOUNDS THERAVANCE BIOPHARMA R&D IP, LLC 2008-10-16 US disclosed
EP-1181274-A4 IMINOCYCLITOL INHIBITORS OF HEXOAMINIDASE AND GLYCOSIDASE SCRIPPS RESEARCH INST (US) 2005-08-17 EP disclosed
EP-1181274-A1 IMINOCYCLITOL INHIBITORS OF HEXOAMINIDASE AND GLYCOSIDASE The Scripps Research Institute (US) 2002-02-27 EP disclosed
WO-2000068194-A1 IMINOCYCLITOL INHIBITORS OF HEXOAMINIDASE AND GLYCOSIDASE THE SCRIPPS RESEARCH INSTITUTE (US) 2000-11-16 WO disclosed